Reply to thread

Message

[QUOTE="Timonen, post: 778334, member: 81"]
I'm pretty close to this issue professionally so I partly want to leave it alone here and partly want to clarify what I know.  Of course it's marketing, but NFPs using marketing as a way to reach folks, grow awareness, fund services, fund research, etc is a win.  Corporate tie-ins to NFP are nothing new.  Advances in cancer for treatment, for prevention, for r&d around new drugs and for availability of patient services for underserved communities are at an all time high...leading to fantastically improved survival rates and care options.  This stuff hasn't happened on its own.  It's because NFPs (and private sector business) puts their resources behind it...and there's a ton more to do.  The share of cancer that's preventable is staggering.  No one program can be everything for everyone, but this sincerely helps with many aspects of breast cancer...and actually has a halo impact on other areas.  Komen money really goes to research.  ACS money really goes to research (another nobel winner last week) and REAL patient services (lodging for patients seeking treatment away from home, rides to treatment, screening programs, etc).  These groups are in the mix on every advancement in the cancer fight.  So yes, it's marketing...and yes, this specific program is not inclusive of all cancers but that doesn't take away from the real impact.
[/QUOTE]

Verification

What is a Syracuse fan's favorite color?